Authors: CREAGAN ET VEEDER MH SUMAN VJ BURCH PA MAPLES WJ SCHAEFER PL PFEIFLE DM DALTON RJ HATFIELD AK POON MA

Citation: Et. Creagan et al., A PHASE-II STUDY OF HIGH-DOSE CIMETIDINE AND THE COMBINATION 5-FLUOROURACIL, INTERFERON ALPHA-2A, AND LEUCOVORIN IN ADVANCED RENAL-CELL ADENOCARCINOMA, American journal of clinical oncology, 21(5), 1998, pp. 475-478

Authors: LOPRINZI CL MESSING EM OFALLON JR POON MA LOVE RR QUELLA SK TRUMP DL MORTON RF NOVOTNY P

Citation: Cl. Loprinzi et al., TOXICITY EVALUATION OF DIFLUOROMETHYLORNITHINE - DOSES FOR CHEMOPREVENTION TRIALS, Cancer epidemiology, biomarkers & prevention, 5(5), 1996, pp. 371-374

Authors: CULLINAN SA MOERTEL CG WIEAND HS OCONNELL MJ POON MA KROOK JE MAILLIARD JA TSCHETTER LK

Citation: Sa. Cullinan et al., CONTROLLED EVALUATION OF 3 DRUG-COMBINATION REGIMENS VERSUS FLUOROURACIL ALONE FOR THE THERAPY OF ADVANCED GASTRIC-CANCER, Journal of clinical oncology, 12(2), 1994, pp. 412-416

Authors: LONG HJ NELIMARK RA SU JQ GARNEAU SC LEVITT R GOLDBERG RM POON MA KUGLER JW

Citation: Hj. Long et al., PHASE-II EVALUATION OF 5-FLUOROURACIL AND LOW-DOSE LEUCOVORIN IN CISPLATIN-REFRACTORY ADVANCED OVARIAN-CARCINOMA, Gynecologic oncology, 54(2), 1994, pp. 180-183